Cellectis Investors
Cellectis is a biopharmaceutical company that develops adoptive immunotherapies for cancer.
%20.jpg)
Technology:
Advanced Longevity (R&D)
Industry:
Advanced and Next Generation Therapies (Various)
Founded Date:
1999
Investor Type:
Healthcare Company
Employee Number:
51-100
Headquarters:
Paris, Ile-de-France, France